HBI hears that the surprise buyer of European imaging and cancer treatment provider Affidea, Groupe Bruxelles Lambert (GBL) may not have been the highest bidder, despite winning out. HBI considers who else was in the running, and the EBITDA figure that may have been used for the deal.
Groupe Bruxelles Lambert (“GBL”) has signed definitive agreements to acquire a majority stake in European imaging and cancer treatment provider Affidea from B-FLEXION, the private investment firm of the Switzerland-based billionaire Bertarelli family. GBL will invest up to €1bn of equity for the transaction which is its first substantive healthcare investment.
Multiple sources say US-based buyout specialist KKR is close to closing a deal to buy Spain-based global fertility player IVI-RMA, the largest group in the sector by revenue.
Almost a year after its IPO, lab giant Synlab has posted strong FY21 results bolstered by Covid, but not, it says, dependant on it. Management say extra cash will be used as a springboard for growth. Could it also lead to private equity majority shareholder Cinven selling its remaining interest?
The new centre-right Czech government will try to liberalise the healthcare market, could introduce supplementary insurance and may even reintroduce hugely unpopular co-pays. HBI talks with Dr Oldrich Subtr, the founder of Program Health Plus, a private polyclinic based in Prague.
CVC Capital Partners has agreed to acquire a co-controlling holding in pan-European IVF provider FutureLife, alongside the company’s current investor Hartenberg Holding.
European imaging and cancer treatment provider Affidea is for sale according to multiple sources. HBI chats to an operator source to find about more about the sale and to speculate on price and purchasers.
Earlier this year elderly care providers in Czechia had been looking to a new public-private partnership in Brno as a model for future agreements. However, HBI hears that the project is already slowing and the market is instead looking to alternative models. HBI speaks to David Volny, CEE-focussed partner at PE firm Dynacor Capital, to find out more.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.OkCookies Policy
